The Effect of Finasteride in Men with Benign Prostatic Hyperplasia
New England Journal of MedicinePublished 22 October 1992Open access
Glenn J. Gormley, Elizabeth Stoner, Reginald C. Bruskewitz, Julianne Imperato‐McGinley, Patrick C. Walsh, John D. McConnell
Citations1,128
SJR quartileQ1
SJR score19.08
SNIP13.47
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The treatment of benign prostatic hyperplasia with 5 mg of finasteride per day results in a significant decrease in symptoms of obstruction, an increase in urinary flow, and a decrease in prostatic volume, but at a slightly increased risk of sexual dysfunction.
Abstract
The treatment of benign prostatic hyperplasia with 5 mg of finasteride per day results in a significant decrease in symptoms of obstruction, an increase in urinary flow, and a decrease in prostatic volume, but at a slightly increased risk of sexual dysfunction.
Keywords
Medicine
ScienceSteroid 5α-Reductase Deficiency in Man: An Inherited Form of Male Pseudohermaphroditism
1,265 Citations1974Julianne Imperato‐McGinley, Luis Guerrero +2 more
In male pseudohermaphrodites born with ambiguity of the external genitalia but with marked virilization at puberty, biochemical evaluation reveals a marked decrease in plasma dihydrotestosterone secondary to a decrease in steroid 5α-reductase activity.
New England Journal of MedicineMortality and Reoperation after Open and Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia
661 Citations1989Noralou P. Roos, John E. Wennberg +6 more
It is suggested that transurethral prostatectomy is less effective in overcoming urinary obstruction than the open operation, and the possibility that transUREthral prostatic hyperplasia may result in higher long-term mortality is raised.
New England Journal of MedicineFamilial Incomplete Male Pseudohermaphroditism, Type 2
626 Citations1974Patrick C. Walsh, James D. Madden +4 more
The demonstration of markedly deficient dihydrotestosterone formation in slices of perineal skin, epididymis and phallus, is compatible with the fact that dihydotestosterone is the fetal hormone responsible for male differentiation of the external genitalia, iscompatible with the idea that androgen resistance in this syndrome is different from that in other androgen-resistant states.
New England Journal of MedicineThe Effect of Nafarelin Acetate, a Luteinizing-Hormone–Releasing Hormone Agonist, on Benign Prostatic Hyperplasia
340 Citations1987Craig A. Peters, Patrick C. Walsh
The findings suggest that androgens have an important supportive role in established benign prostatic hyperplasia and that testicular suppression will benefit some patients, however, this form of treatment could be applicable only in carefully selected patients who were not surgical candidates, and it would need to be maintained indefinitely.
American Journal of EpidemiologyTHE DEVELOPMENT OF BENIGN PROSTATIC HYPERPLASIA AMONG VOLUNTEERS IN THE NORMATIVE AGING STUDY
325 Citations1985Robert J. Glynn, Edward W. Campion +2 more
This study describes the development of benign prostatic hyperplasia among 2,036 volunteers in the Veterans Administration Normative Aging Study, a longitudinal study of human aging situated in Boston.
The Journal of Steroid Biochemistry and Molecular BiologyThe clinical development of a 5α-reductase inhibitor, finasteride
221 Citations1990Elizabeth Stoner
Selective inhibition of 5 alpha-reductase by finasteride may provide a novel approach to BPH therapy by reducing prostate size without affecting T-dependent processes such as fertility, muscle strength, and libido.
The Journal of UrologyMale Peak Urinary Flow Rate: Relationships to Volume Voided and Age
203 Citations1979George W. Drach, Terry N. Layton +1 more
It is suggested that a voided volume of 150 ml.
The Journal of UrologyThe Efficacy of Transurethral Resection of the Prostate in Men with Moderate Symptoms of Prostatism
186 Citations1990Herbert Lepor, Gilbert Rigaud
The degree of improvement in urinary flow rates and symptom scores achieved after transurethral prostatectomy exceeds all other therapeutic options that presently are available for the treatment of benign prostatic hyperplasia.
The Journal of UrologyThe Clinical Effects of a 5α-Reductase Inhibitor, Finasteride, on Benign Prostatic Hyperplasia
166 Citations1992Elizabeth Stoner
The effects of finasteride in patients with benign prostatic hyperplasia were investigated in 2 double-blind, placebo-controlled studies, showing significant decreases in prostate volume and lower doses had a lesser effect on prostate shrinkage.
The Journal of Clinical Endocrinology & MetabolismEffects of Finasteride (MK-906), a 5<i>α</i>-Reductase Inhibitor, on Circulating Androgens in Male Volunteers*
161 Citations1990Glenn J. Gormley, Elizabeth Stoner +6 more
Finasteride is well tolerated by normal volunteers and results in significant suppression of serum DHT at all doses tested, and the T/DHT ratio increased with all doses and returned to baseline when drug was discontinued.
The Journal of UrologyTreatment of Benign Prostatic Hyperplasia by Androgen Deprivation: Effects on Prostate Size and Urodynamic Parameters
100 Citations1989Ruud Bosch, Derek Griffiths +2 more
The clinical indication for use of medical androgen deprivation in benign prostatic hyperplasia patients will remain limited for the time being because of the minimal urodynamic changes.
Natural History of Benign Prostatic Hypertrophy
86 Citations1983John D. Birkhoff
These studies involved different countries as well as different populations within a given country, and so the patient groups being evaluated may not have been typical of the population as a whole, but reviewing these studies allows us to get an overall picture of the incidence and natural history of BPH.
Journal of AndrologyEffect of MK‐906, a Specific 5α‐reductase Inhibitor, on Serum Androgens and Androgen Conjugates in Normal Men
84 Citations1989Roger S. Rittmaster, Elizabeth Stoner +3 more
While all three steroids appeared to be good markers of systemic 5 alpha-reductase inhibition, further research will be needed to determine which steroid best reflects tissue DHT levels in patients receiving these inhibitors.
The ProstateCritical evaluation of transurethral resection and incision of the prostate
36 Citations1990Reginald C. Bruskewitz, Mads M. Christensen
Next to cataract extraction, surgical treatment of benign prostatic hyperplasia is the second most prevalent surgical procedure in the United States, with an estimated 400,000 trarnsurethral resection procedures performed annually.
UrologySerum prostate-antigen levels in patients with benign prosttic hypertrophy treated with leuprolide
29 Citations1989Alice C. Levine, Alexander Kirschenbaum +3 more
It is concluded that treatment with a GnRH analogue caused reversible involution of prostatic epithelial cells with parallel effects on serum PSA levels which paralleled the decrease in prostate size.
Origins, Distribution, and Risk of Benign Prostatic Hypertrophy
28 Citations1983I. D. Rotkin
That prostatic hypertrophy occurs so universally and is readily treatable does not detract from the observation that it has long been a condition that, with many other maturity-associated setbacks, can be expected to contain the life span of some men.
Development of Nomograms for Application of Uroflowmetry
17 Citations1983Jacques G. Susset
Uroflowmetry is now recognized as an essential diagnostic tool in the assessment of urinary dysfunction, particularly that due to lower tract obstruction, and it is necessary to develop a system of interpretation based on reference to normal values.